Cargando…

HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma

Vulvar carcinoma is the fourth most common gynecological malignancy. Two separate carcinogenic pathways are suggested, where one is associated with the human papillomavirus (HPV) and HPV16 the most common genotype. The aim of this study was to evaluate HPV-markers in a set of primary tumors, metasta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lillsunde Larsson, Gabriella, Kaliff, Malin, Sorbe, Bengt, Helenius, Gisela, Karlsson, Mats G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249404/ https://www.ncbi.nlm.nih.gov/pubmed/30391517 http://dx.doi.org/10.1016/j.pvr.2018.10.008

Ejemplares similares

Viral Load, Integration and Methylation of E2BS3 and 4 in Human Papilloma Virus (HPV) 16-Positive Vaginal and Vulvar Carcinomas
por: Lillsunde Larsson, Gabriella, et al.
Publicado: (2014)

HPV-negative Tumors in a Swedish Cohort of Cervical Cancer
por: Kaliff, Malin, et al.
Publicado: (2020)

Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy
por: Kaliff, Malin, et al.
Publicado: (2018)

Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda
por: Kumakech, Edward, et al.
Publicado: (2016)

Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus–positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden
por: Kaliff, Malin, et al.
Publicado: (2022)

Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?
por: Qvick, Alvida, et al.
Publicado: (2017)

Digital droplet PCR (ddPCR) for the detection and quantification of HPV 16, 18, 33 and 45 - a short report
por: Lillsunde Larsson, Gabriella, et al.
Publicado: (2017)

HPV-based screening for cervical cancer among women 55-59 years of age
por: Bergengren, Lovisa, et al.
Publicado: (2019)

Molecular triage of cervical screening samples in women 55–59 years of age: a pilot study
por: Helenius, Gisela, et al.
Publicado: (2023)

Evaluation of dyskerin expression and the Cajal body protein WRAP53β as potential prognostic markers for patients with primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2022)

Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2017)

Detection of High- and Low-Risk HPV DNA in Archived Breast Carcinoma Tissues from Ethiopian Women
por: Gebregzabher, Endale, et al.
Publicado: (2021)

Human papillomavirus prevalence and genotype distribution among young women and men in Maputo city, Mozambique
por: Edna Omar, Viegas, et al.
Publicado: (2017)

Effectiveness and costs of an implemented primary HPV cervical screening programme in Sweden – A population based cohort study
por: Bergengren, Lovisa, et al.
Publicado: (2021)

Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women
por: Hermansson, Ruth S., et al.
Publicado: (2022)

Vulvar Buschke-Löwenstein tumor in a HPV 16 infected woman: case report
por: Ernez, Safia, et al.
Publicado: (2022)

Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease
por: Ghelardi, Alessandro, et al.
Publicado: (2021)

HPV prevalence in vulvar cancer in Austria
por: Pils, Sophie, et al.
Publicado: (2017)

Anti-HPV16 E2 Protein T-Cell Responses and Viral Control in Women with Usual Vulvar Intraepithelial Neoplasia and Their Healthy Partners
por: Jacobelli, Simon, et al.
Publicado: (2012)

Natural history of recurrences in endometrial carcinoma
por: SORBE, BENGT, et al.
Publicado: (2014)

HPV-associated vulvar carcinoma with sebaceous differentiation
por: Kuan, Irena, et al.
Publicado: (2023)

Outcome of vulvar reconstruction in patients with advanced and recurrent vulvar malignancies
por: Zhang, Wei, et al.
Publicado: (2015)

Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence
por: Bechini, Angela, et al.
Publicado: (2023)

Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines
por: Praiss, Aaron, et al.
Publicado: (2022)

Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma
por: Falck, Eva, et al.
Publicado: (2010)

A Very Rare Case: HPV-Negative Vulvar Cancer in an Adolescent
por: Kahramanoglu, Ilker, et al.
Publicado: (2018)

Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma
por: Sorbe, Bengt
Publicado: (2012)

Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)
por: Madeleine, Margaret M., et al.
Publicado: (2016)

Significance of HPV16 Viral Load Testing in Anal Cancer
por: Małusecka, Ewa, et al.
Publicado: (2020)

HPV status and HPV16 viral load in anal cancer and its association with clinical outcome
por: Guerendiain, Daniel, et al.
Publicado: (2022)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013)

Recurrence of vulvar carcinoma: A multidisciplinary approach
por: Rei, M., et al.
Publicado: (2019)

Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV
por: Rodrigues, I S, et al.
Publicado: (2013)

What to do when nothing else is left to be done - metastatic non-HPV vulvar squamous cell carcinoma with multiple lines of chemotherapy
por: Stana, Mihaela Mărioara, et al.
Publicado: (2021)

HPV16 persistent infection and recurrent disease after LEEP
por: Bruno, Maria Teresa, et al.
Publicado: (2019)

Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination
por: Abdulrahman, Ziena, et al.
Publicado: (2020)

Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer
por: Thangarajah, Fabinshy, et al.
Publicado: (2023)

The re-infection rate of high-risk HPV and the recurrence rate of vulvar intraepithelial neoplasia (VIN) usual type after surgical treatment
por: Frega, Antonio, et al.
Publicado: (2011)

Analysis of the Vulvar Skin Microbiota in Asymptomatic Women and Patients With Vulvar Lichen Sclerosus Based on 16S rRNA Sequencing
por: Liu, Xiaoxiao, et al.
Publicado: (2022)

Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status
por: Wendt, Malin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fsiu208c9516oegui7c2mt1omt